Rapid Pituitary Tumor Shrinkage with Dissociation between Antiproliferative and Antisecretory Effects of a Long-Acting Octreotide in an Acromegalic Patient | Zendy

Eugenia Resmini | Zendy; Patrizia Dadati | Zendy; Jean-Luis Ravetti | Zendy; Gianluigi Zona | Zendy; Renato Spaziante | Zendy; Alexandru Saveanu | Zendy; P Jaquet | Zendy; Michael D. Culler | Zendy; Federico Bianchi | Zendy; Alberto Rebora | Zendy; Francesco Minuto | Zendy; Diego Ferone | Zendy

Open Access

Rapid Pituitary Tumor Shrinkage with Dissociation between Antiproliferative and Antisecretory Effects of a Long-Acting Octreotide in an Acromegalic Patient

Author(s) -

Eugenia Resmini,

Patrizia Dadati,

Jean-Luis Ravetti,

Gianluigi Zona,

Renato Spaziante,

Alexandru Saveanu,

P Jaquet,

Michael D. Culler,

Federico Bianchi,

Alberto Rebora,

Francesco Minuto,

Diego Ferone

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-2084

Subject(s) - somatostatin , somatostatin receptor , acromegaly , octreotide , receptor , agonist , endocrinology , medicine , chemistry , receptor expression , somatostatin receptor 2 , cell growth , cancer research , biology , hormone , biochemistry , growth hormone

Criteria to define the response to somatostatin (SS) analogs (SSA) in acromegaly are based on biochemical control of the disease. However, the mechanisms of action of SSAs in inhibiting tumor growth and hormonal secretion are only partially understood, and the two effects may occur independently.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research